p-Toluidine → Benzenesulfonamide, N-(4-methylphenyl)-4-nitro-
반응식
[N+:1]([C:4]1[CH:9]=[CH:8][C:7]([S:10]([NH:13][C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=2[CH3:20])(=[O:12])=[O:11])=[CH:6][CH:5]=1)([O-:3])=[O:2].NC1C=CC(C)=CC=1>>[N+:1]([C:4]1[CH:5]=[CH:6][C:7]([S:10]([NH:13][C:14]2[CH:15]=[CH:20][C:17]([CH3:16])=[CH:18][CH:19]=2)(=[O:11])=[O:12])=[CH:8][CH:9]=1)([O-:3])=[O:2]참가 물질
3
실험 절차
(RK1-1-29)I This compound was prepared according to the procedure described for compound 11a except using p-toluidine to obtain required product as a yellow solid, (256 mg, 97%). Mp=170-172° C. (lit 184-184.5° C. Bioorganic and Medicinal Chemistry 15(2), 1014-1021; 2007); 1H NMR (400 MHz, CDCl3) δ 8.27 (d, J=9.0 Hz, 2H), 7.88 (d, J=9.0 Hz, 2H), 7.08 (d, J=8.2 Hz, 2H), 6.94 (d, J=8.2 Hz, 2H), 6.41 (bs, 1H), 2.30 (s, 3H).
후처리
- custom(RK1-1-29)I This compound was prepared
출처 및 근거
- ORD 기록
- ord-961b2154f68e4004bcb79e72d70b85d1